Tata India Pharma & Healthcare Fund Direct Growth

Tata India Pharma & Healthcare Fund Direct Growth

Get the latest NAV of Tata India Pharma & Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹33.58

1.2%1D

NAV as on 12 May 2025

13.8%/per year

Since Inception

Absolute Gain%

2606 people have invested ₹ 1.3Cr in Tata India Pharma & Healthcare Fund Direct Growth in the last three months

Tata India Pharma & Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (12-May-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
3.32%
8.47%
3.21%
3 Months
1.7%
7.67%
1.68%
6 Months
-2.41%
0.81%
-3.86%
1 Year
18.47%
9.98%
18.38%
3 Years
25.03%
18.69%
22.56%
5 Years
23.68%
24.52%
21.85%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
Tata India Pharma & Healthcare Fund
2/8
1,223Cr
0.67%
18.47%
25.03%
13.8%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,671Cr
0.9%
22.04%
28.99%
18.15%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
3/8
4,915Cr
1.18%
23.79%
28.39%
22.38%
DSP Healthcare Fund Direct Growth
4/8
2,912Cr
0.63%
13.56%
24.86%
24.03%
img
3Y returns in the top 25% of the category
img
Beats FD returns for both 3Y & 5Y duration
img
No bad points found for this fund.

Tata India Pharma & Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit


Total Corpus

0

Absolute Return

Tata India Pharma & Healthcare Fund Asset Allocation

See fund asset allocation details as on (15-Apr-25)

Fund Distribution

as on (15-Apr-25)

Equity 93.4%

Debt & Cash 6.6%

Mid cap
32.7%

Large cap
30.2%

Small cap
29.1%

Mid Cap allocation has gone up from 33% to 34.1%
Mid Cap allocation has gone up from 33% to 34.1%
Large Cap allocation has gone down from 35.9% to 29.7%
Large Cap allocation has gone down from 35.9% to 29.7%
Small Cap allocation has gone up from 27.4% to 30.2%
Small Cap allocation has gone up from 27.4% to 30.2%
Cash allocation has gone up from 1.9% to 4.2%
Cash allocation has gone up from 1.9% to 4.2%

Tata India Pharma & Healthcare Fund Sector Allocation

See fund sector allocation details as on (15-Apr-25)

Sector Allocation

Equity 93.4%

Debt & Cash 6.6%

Health
97.9%
Basic Materials
2.1%

Top 2 Sectors in March were Health, Basic Materials

Mar'25

Health

98%

Basic Materials

2%

Feb'25

Health

98%

Basic Materials

2%

Tata India Pharma & Healthcare Fund Holdings Details

as on (30-Apr-25)

Equity

Top Stocks bought last month
Apollo Hospitals Enterprise Ltd's allocation increased from 3.98% to 5.66%
Apollo Hospitals Enterprise Ltd's allocation increased from 3.98% to 5.66%
Metropolis Healthcare Ltd's allocation increased from 1.11% to 1.8%
Metropolis Healthcare Ltd's allocation increased from 1.11% to 1.8%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 3.31% to 3.91%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 3.31% to 3.91%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 6.25 % to 5.97 %
Cipla Ltd's allocation decreased from 6.25 % to 5.97 %
Lupin Ltd's allocation decreased from 6.22 % to 5.2 %
Lupin Ltd's allocation decreased from 6.22 % to 5.2 %
Divi's Laboratories Ltd's allocation decreased from 5.21 % to 5.12 %
Divi's Laboratories Ltd's allocation decreased from 5.21 % to 5.12 %

Tata India Pharma & Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.67%
Benchmark
Nifty Pharma TR INR
AUM₹1223 Cr
Inception Date28 December, 2015
Min Lumpsum/SIP₹5000/₹100
Exit Load
0.2%
Lock InNo Lock-in
TurnOver
28.44%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About Tata India Pharma & Healthcare Fund

Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Tata India Pharma & Healthcare Fund Direct Growth has ₹1223 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
  2. The fund has an expense ratio 0.7.

Returns

Tata India Pharma & Healthcare Fund Direct Growth has given a CAGR return of 13.80% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 18.47%, 25.03% and 23.68% respectively.

Holdings

Tata India Pharma & Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Apollo Hospitals Enterprise Ltd, Divi's Laboratories Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Tata India Pharma & Healthcare Fund Direct Growth

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Tata India Pharma & Healthcare Fund Direct Growth has no lock in period.

Fund Manager

Meeta Shetty

Fund Manager of Tata India Pharma & Healthcare Fund Direct Growth, since 9 March 2021

Learn more about Tata Mutual Fund
Parameters
Mar'25
Feb'25
Jan'25
AUM
₹ 1.2K Cr
₹ 1.1K Cr
₹ 1.2K Cr
  • AUM of the fund stands at 1.2K Cr as of Mar'25
  • AUM increased by 79.7 Cr between Mar'25 and Feb'25

Compare Tata India Pharma & Healthcare Fund

Tata India Pharma & Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for Tata India Pharma & Healthcare Fund Direct Growth

What is the current NAV of Tata India Pharma & Healthcare Fund Direct Growth?

The current NAV of Tata India Pharma & Healthcare Fund Direct Growth is ₹33.58 as on 12-May-2025.

What are the average returns of Tata India Pharma & Healthcare Fund Direct Growth?

Existing (Absolute + CAGR) as on 12-May-2025.
Tata India Pharma & Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
3.32%
3.32%
6 Month Returns
-2.41%
-2.41%
1 Year Returns
18.47%
18.47%
3 Years Returns
95.47%
25.03%

How do I invest in Tata India Pharma & Healthcare Fund Direct Growth?

With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.

What is the expense ratio of Tata India Pharma & Healthcare Fund Direct Growth?

0.67% as on April 2025

What is net assets under management (AUM) of Tata India Pharma & Healthcare Fund Direct Growth?

₹1223 Cr as on April 2025

What are the top 5 holdings of Tata India Pharma & Healthcare Fund Direct Growth?

Sun Pharmaceuticals Industries Ltd(12.8%), Cipla Ltd(6.21%), Aurobindo Pharma Ltd(6.18%), Apollo Hospitals Enterprise Ltd(5.78%), Divi's Laboratories Ltd(5.23%) as on April 2025

What is the alpha of Tata India Pharma & Healthcare Fund Direct Growth?

The alpha ratio for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
2.49
3.78
4.92
As on April 2025
The alpha for Tata India Pharma & Healthcare Fund Direct Growth is calculated against Nifty Pharma TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

What is the beta of Tata India Pharma & Healthcare Fund Direct Growth??

The Beta ratio for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
1
0.95
0.91
As on April 2025
The Beta for Tata India Pharma & Healthcare Fund Direct Growth is calculated with Nifty Pharma TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

What is the sharpe ratio of Tata India Pharma & Healthcare Fund Direct Growth?

The sharpe ratio for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
0.59
0.91
1.09
As on April 2025
The sharpe ratio for Tata India Pharma & Healthcare Fund Direct Growth is calculated with Nifty Pharma TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

What is the standard deviation of Tata India Pharma & Healthcare Fund Direct Growth?

The standard deviation for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
20.6
16.72
16.11
As on April 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

What is the Sortino ratio of Tata India Pharma & Healthcare Fund Direct Growth?

Sortino ratio is 1.59 as on April 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.

What is the information ratio of Tata India Pharma & Healthcare Fund Direct Growth?

Information ratio is 1.26 as on April 2025. It tells the consistency of the fund in generating superior risk-adjusted performance

Who is the manager of Tata India Pharma & Healthcare Fund Direct Growth?

Meeta Shetty is the fund manager of Tata India Pharma & Healthcare Fund Direct Growth

What is the exit load of Tata India Pharma & Healthcare Fund Direct Growth?

The Exit load of Tata India Pharma & Healthcare Fund Direct Growth is 0.25%